Pricing Log in Create free account

Achieve Life Sciences, Inc. (ACHV) vs ArriVent BioPharma, Inc. (AVBP)

Achieve Life Sciences, Inc. and ArriVent BioPharma, Inc. are both Biotechnology companies. Achieve Life Sciences, Inc. and ArriVent BioPharma, Inc. are of similar size ($665.2M and $658.6M). Across the 8 metrics below, Achieve Life Sciences, Inc. leads on 5 and ArriVent BioPharma, Inc. on 3.

Valuation

Metric ACHV AVBP Biotechnology median
P/E n/m n/m 10.96
P/S 40.07 n/m 9.52
P/B n/m 1.77 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 29.26 n/m 9.00
Earnings yield (22.86%) (26.86%) (32.09%)
Free cash flow yield (7.42%) (22.76%) (22.62%)

Profitability

Metric ACHV AVBP Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (844.99%) (53.10%) (50.12%)
Return on assets (91.46%) (49.30%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACHV AVBP Biotechnology median
Revenue growth (TTM) (5.58%) — 6.78%
EPS growth (last fiscal year) (0.81%) (68.75%) 29.88%
Revenue growth, 5-year CAGR (17.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACHV AVBP Biotechnology median
Debt to equity (1.11) 0.00 0.00
Current ratio 0.95 14.16 4.74
Net debt to EBITDA 0.36 1.73 1.01

Dividend

Metric ACHV AVBP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ACHV AVBP Biotechnology median
Market cap 658.58m 665.16m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack